Skip to content
WealthTicker

Compare

NAVs as of 20 Aug 2026

Sundaram Aggressive Hybrid Fund - Direct Plan - Monthly IDCW (Direct · IDCW1 of 4 funds

Add a second fund to compare. Until then every figure below is shown against the Aggressive Hybrid Fund median (46 funds), which is the only comparison one fund can support.

Growth of ₹100 (rebased over the selected window)

Common period 03 Jan 202220 Aug 2026, limited by Sundaram Aggressive Hybrid Fund - Direct Plan - Monthly IDCW (. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.

View as table
Growth of ₹100, sampled across the common period
DateSundaram Aggressive Hybrid Fund - Direct Plan - Monthly IDCW (Nifty 50
03 Jan 2022₹100.00₹100.00
24 May 2022₹87.89₹91.49
12 Oct 2022₹91.87₹97.15
02 Mar 2023₹87.22₹98.28
20 Jul 2023₹93.26₹113.35
08 Dec 2023₹96.32₹118.97
27 Apr 2024₹101.18₹127.20
15 Sep 2024₹111.64₹143.86
03 Feb 2025₹100.17₹132.54
24 Jun 2025₹102.52₹142.09
11 Nov 2025₹102.12₹145.78
01 Apr 2026₹88.96₹128.67
20 Aug 2026₹93.58₹137.48
Sundaram Aggressive Hybrid Fund - Direct Plan - Monthly IDCW ( compared on return, risk, benchmark-relative, cost and portfolio metrics, against the Aggressive Hybrid Fund median.
Metric
Sundaram · Direct · IDCW
NAV ₹39.31
High risk
★☆☆☆☆
Category median
Aggressive Hybrid Fund · 46 funds
-7.97%-0.13%
+0.60%+8.71%
+9.07%
+6.41%
-1.42%+8.71%
-1.23%
+2.47%+9.75%
+10.21%
+7.64%
Risk
10.37%11.39%
-0.570.19
-0.750.26
-22.42%-30.66%
Nifty 50
-7.17%+0.53%
0.790.79
65.3%83.6%
99.6%66.2%
1.17%1.10%
₹2,139Cr₹701.99Cr
Up to 1.00%
None
₹100
₹100
65%37%
Ratish B Varier
03 Jan 2022
55
30.8%
6.3%

Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.